Shu-Hua Teng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shu-Hua Teng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Niu Niu
School of Materials Science and Engineering, China University of Mining and Technology, Xuzhou 221116, Jiangsu, China
4 shared publications- Peng Wang
School of Materials Science and Engineering, China University of Mining and Technology, Xuzhou 221116, Jiangsu, China
4 shared publications Peng Wang
School of Materials Science and Physics, China University of Mining and Technology Xuzhou China
3 shared publicationsFeng-Wu Chen
China University of Mining and Technology, Xuzhou, Jiangsu, China
2 shared publications- Haisheng Qian
School of Biomedical Engineering Anhui Medical University Hefei P. R. China
2 shared publications Ke Xue
School of Materials Science and Engineering, China University of Mining and Technology, Xuzhou 221116, Jiangsu, China
2 shared publications
Latest Publications
- 26 August 2026
- Published by Wiley in Polymer Engineering & Science
- Vol. 66 (11) , 8400-8413
Synergistic Performance Optimization of Polyvinyl Alcohol Hydrogels via Silica and Pluronic F127 Incorporation for Biomedical Applications
Optimizing conventional hydrogels is crucial for their broader and more effective biomedical applications. This study aims to enhance the mechanical properties and biofunctions of physically crosslinked polyvinyl alcohol (PVA) hydrogels by introducing silica (SiO 2 ) and Pluronic 127 (F127), eventually resulting in a novel PVA‐SiO 2 ‐F127 composite hydrogel with a weight ratio of 7:3:5. The obtained hydrogels exhibited a super‐hydrophilic surface (contact angle of ~0°) and a more compact network than pure PVA hydrogels, as confirmed by the SEM analysis. The addition of SiO 2 effectively improved the compatibility between PVA and F127 through mutual hydrogen bonding, which was verified by the FT‐IR results. Meanwhile, it endowed the PVA hydrogels with an excellent ability to form bone‐like apatite. The further incorporation of F127 enhanced the compressive strength of the PVA hydrogels by 144% (from 0.09 to 0.22 MPa at 70% strain) and accelerated the weight loss from 11.1% to 31.5% over 10 days in PBS, while maintaining a high swelling capacity of 616.7%. In addition, the feasibility of the composite hydrogel as a carrier of bovine serum albumin (BSA) was evaluated at different temperatures (4°C, 25°C, 37°C, and 45°C). Results revealed a temperature‐dependent, sustained BSA release profile over 240 h, with an optimal release behavior at 37°C (body temperature). The release kinetics were synergistically controlled by diffusion and erosion processes. Compared to PVA hydrogels, the composite hydrogels minimized the initial burst release and prolonged the stability of BSA over extended periods, thereby highlighting their potential applications in wound healing and tissue engineering.
- 26 August 2026
- Published by Wiley in Polymer Engineering & Science
- Vol. 66 (11) , 8400-8413
Synergistic Performance Optimization of Polyvinyl Alcohol Hydrogels via Silica and Pluronic F127 Incorporation for Biomedical Applications
Optimizing conventional hydrogels is crucial for their broader and more effective biomedical applications. This study aims to enhance the mechanical properties and biofunctions of physically crosslinked polyvinyl alcohol (PVA) hydrogels by introducing silica (SiO 2 ) and Pluronic 127 (F127), eventually resulting in a novel PVA‐SiO 2 ‐F127 composite hydrogel with a weight ratio of 7:3:5. The obtained hydrogels exhibited a super‐hydrophilic surface (contact angle of ~0°) and a more compact network than pure PVA hydrogels, as confirmed by the SEM analysis. The addition of SiO 2 effectively improved the compatibility between PVA and F127 through mutual hydrogen bonding, which was verified by the FT‐IR results. Meanwhile, it endowed the PVA hydrogels with an excellent ability to form bone‐like apatite. The further incorporation of F127 enhanced the compressive strength of the PVA hydrogels by 144% (from 0.09 to 0.22 MPa at 70% strain) and accelerated the weight loss from 11.1% to 31.5% over 10 days in PBS, while maintaining a high swelling capacity of 616.7%. In addition, the feasibility of the composite hydrogel as a carrier of bovine serum albumin (BSA) was evaluated at different temperatures (4°C, 25°C, 37°C, and 45°C). Results revealed a temperature‐dependent, sustained BSA release profile over 240 h, with an optimal release behavior at 37°C (body temperature). The release kinetics were synergistically controlled by diffusion and erosion processes. Compared to PVA hydrogels, the composite hydrogels minimized the initial burst release and prolonged the stability of BSA over extended periods, thereby highlighting their potential applications in wound healing and tissue engineering.
- 12 March 2025
- Published by Springer Nature in Frontiers of Materials Science
- Vol. 19 (1) , 1-10
Surfactant-free emulsion electrospinning of curcumin-loaded poly(ε-caprolactone)/bovine serum albumin composite fibers for biomedical applications
- 12 March 2025
- Published by Springer Nature in Frontiers of Materials Science
- Vol. 19 (1) , 1-10
Surfactant-free emulsion electrospinning of curcumin-loaded poly(ε-caprolactone)/bovine serum albumin composite fibers for biomedical applications
- Open Access
- 24 December 2020
- Published by Wiley in Journal of Nanomaterials
- Vol. 2020, 1-6
Green Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications
A facile and green method was explored to prepare the tetracycline hydrochloride- (TCH-) loaded poly (ε-caprolactone)-chitosan-silica xerogel (PCL-CS-SiO2) hybrid fibers by using 90% acetic acid as a suitable solvent. The SEM results showed that those fibers exhibited a continuous, bead-free morphology, an average diameter of about 430 nm, and super-hydrophilicity ( ). The presence of SiO2 was found to enhance the thermal stability of the hybrid fibers, and the actual content of SiO2 was obtained by the TG measurement. Moreover, SiO2 xerogel as an important bioceramic endowed the hybrid fibers with good drug release behavior and in vitro bioactivity, suggesting their potential use as novel drug carriers for bone tissue engineering. The present work is expected to offer a green strategy to develop novel, multifunctional hybrid materials.
- 24 December 2020
- Published by Wiley in Journal of Nanomaterials
- Vol. 2020, 1-6
Open AccessGreen Strategy to Develop Novel Drug-Containing Poly (ε-Caprolactone)-Chitosan-Silica Xerogel Hybrid Fibers for Biomedical Applications
A facile and green method was explored to prepare the tetracycline hydrochloride- (TCH-) loaded poly (ε-caprolactone)-chitosan-silica xerogel (PCL-CS-SiO2) hybrid fibers by using 90% acetic acid as a suitable solvent. The SEM results showed that those fibers exhibited a continuous, bead-free morphology, an average diameter of about 430 nm, and super-hydrophilicity ( ). The presence of SiO2 was found to enhance the thermal stability of the hybrid fibers, and the actual content of SiO2 was obtained by the TG measurement. Moreover, SiO2 xerogel as an important bioceramic endowed the hybrid fibers with good drug release behavior and in vitro bioactivity, suggesting their potential use as novel drug carriers for bone tissue engineering. The present work is expected to offer a green strategy to develop novel, multifunctional hybrid materials.
- 27 September 2019
- Published by Elsevier in Materials Letters
- Vol. 257, 126746
One-pot synthesis of novel tri-component composite microspheres of polyvinyl alcohol-silica-hydroxyapatite for biomedical applications
- 27 September 2019
- Published by Elsevier in Materials Letters
- Vol. 257, 126746
One-pot synthesis of novel tri-component composite microspheres of polyvinyl alcohol-silica-hydroxyapatite for biomedical applications
- Open Access
- 14 August 2019
- Published by Wiley in Journal of Nanomaterials
- Vol. 2019, 1-7
Synthesis, Characterization, and In Vitro Drug Delivery of Chitosan-Silica Hybrid Microspheres for Bone Tissue Engineering
Chitosan-silica (CS-SiO2) hybrid microspheres were prepared through the combined process of sol-gel and emulsification-crosslinking. Their composition, morphology, in vitro bioactivity, and drug release behavior were investigated. The results showed that, when 20 wt% SiO2 was incorporated, the as-prepared CS-SiO2 hybrid microspheres exhibited a regular spherical shape, a high dispersity, and a uniform microstructure. Their average particle diameter was determined to be about 24.0 μm. The in situ deposited inorganic phase of the hybrid microspheres was identified as amorphous SiO2, and its actual content was determined by the TG analysis. As compared with the pure chitosan microspheres, the CS-SiO2 hybrid microspheres displayed a greatly improved in vitro bioactivity. Vancomycin hydrochloride (VH) was selected as a model drug. It was demonstrated that the CS-SiO2 hybrid microspheres presented a good capacity for both loading and sustained release of VH. Moreover, the increase of the SiO2 content efficiently slowed down the drug release rate of the CS-SiO2 hybrid microspheres.
- 14 August 2019
- Published by Wiley in Journal of Nanomaterials
- Vol. 2019, 1-7
Open AccessSynthesis, Characterization, and In Vitro Drug Delivery of Chitosan-Silica Hybrid Microspheres for Bone Tissue Engineering
Chitosan-silica (CS-SiO2) hybrid microspheres were prepared through the combined process of sol-gel and emulsification-crosslinking. Their composition, morphology, in vitro bioactivity, and drug release behavior were investigated. The results showed that, when 20 wt% SiO2 was incorporated, the as-prepared CS-SiO2 hybrid microspheres exhibited a regular spherical shape, a high dispersity, and a uniform microstructure. Their average particle diameter was determined to be about 24.0 μm. The in situ deposited inorganic phase of the hybrid microspheres was identified as amorphous SiO2, and its actual content was determined by the TG analysis. As compared with the pure chitosan microspheres, the CS-SiO2 hybrid microspheres displayed a greatly improved in vitro bioactivity. Vancomycin hydrochloride (VH) was selected as a model drug. It was demonstrated that the CS-SiO2 hybrid microspheres presented a good capacity for both loading and sustained release of VH. Moreover, the increase of the SiO2 content efficiently slowed down the drug release rate of the CS-SiO2 hybrid microspheres.
- 17 January 2019
- Published by IOP Publishing in Materials Research Express
- Vol. 6 (5) , 055201
Polyvinyl alcohol/silica hybrid microspheres: synthesis, characterization and potential applications as adsorbents
Polyvinyl alcohol/silica (PVA/SiO2) hybrid microspheres with different SiO2 contents were prepared via a sol-gel combined emulsification process. When 20 wt% SiO2 was contained, the hybrid microspheres (~13.3 μm in average diameter) presented the most desirable morphology with good spherical shape, high dispersity and uniform particle size. Silica xerogel existed as an amorphous phase in the microspheres, and its actual content was determined by the TG analysis. The feasibility of the hybrid microspheres as a novel adsorbent to remove Rhodamine B (RhB) was preliminary evaluated in aqueous solutions. A kinetic study indicated that the adsorption data were well represented by the pseudo-second-order model. Moreover, the removal efficiency of RhB by the hybrid microspheres was found to depend strongly on the SiO2 content. Under the optimal adsorption conditions, the hybrid microspheres with 20 wt% SiO2 exhibited the highest removal percentage of RhB (~88.4%), indicating their great potential to be used in water treatment applications.
- 17 January 2019
- Published by IOP Publishing in Materials Research Express
- Vol. 6 (5) , 055201
Polyvinyl alcohol/silica hybrid microspheres: synthesis, characterization and potential applications as adsorbents
Polyvinyl alcohol/silica (PVA/SiO2) hybrid microspheres with different SiO2 contents were prepared via a sol-gel combined emulsification process. When 20 wt% SiO2 was contained, the hybrid microspheres (~13.3 μm in average diameter) presented the most desirable morphology with good spherical shape, high dispersity and uniform particle size. Silica xerogel existed as an amorphous phase in the microspheres, and its actual content was determined by the TG analysis. The feasibility of the hybrid microspheres as a novel adsorbent to remove Rhodamine B (RhB) was preliminary evaluated in aqueous solutions. A kinetic study indicated that the adsorption data were well represented by the pseudo-second-order model. Moreover, the removal efficiency of RhB by the hybrid microspheres was found to depend strongly on the SiO2 content. Under the optimal adsorption conditions, the hybrid microspheres with 20 wt% SiO2 exhibited the highest removal percentage of RhB (~88.4%), indicating their great potential to be used in water treatment applications.
- 7 September 2018
- Published by IOP Publishing in Materials Research Express
- Vol. 5 (11) , 115401
Biomimetic synthesis of novel polyvinyl alcohol/hydroxyapatite composite microspheres for biomedical applications
- 7 September 2018
- Published by IOP Publishing in Materials Research Express
- Vol. 5 (11) , 115401
Biomimetic synthesis of novel polyvinyl alcohol/hydroxyapatite composite microspheres for biomedical applications
- 14 June 2016
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 79 (3) , 525-529
One-pot synthesis of polyvinyl alcohol/silica composite microspheres in a surfactant-free system for biomedical applications
- 14 June 2016
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 79 (3) , 525-529
One-pot synthesis of polyvinyl alcohol/silica composite microspheres in a surfactant-free system for biomedical applications